Back to Search
Start Over
Spain : New Phase 3 Data show Anti-TNF Alpha Simponi Aria (golimumab) Significantly Improved Arthritis and Skin Manifestations In Patients With Active Psoriatic Arthritis
- Source :
- Mena Report. June 15, 2017
- Publication Year :
- 2017
-
Abstract
- Janssen Research & Development, LLC (Janssen) announced today results from the pivotal Phase 3 GO-VIBRANT study that showed the significant efficacy of the intravenously administered anti-tumor necrosis factor (TNF)-alpha therapy [...]
Details
- Language :
- English
- ISSN :
- 22190112
- Database :
- Gale General OneFile
- Journal :
- Mena Report
- Publication Type :
- News
- Accession number :
- edsgcl.504268704